Company / Capital Returned to Shareholders per Share
Amgen Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$9.54
FY2025
5-year range
$8.53 / $18.91
FY2021-FY2025
Trend
+1.5%
vs FY2024
Sector context
#4 of 51
Health Care
What the data says
Among 51 Health Care companies, Amgen is in the top 8% for capital returned to shareholders per share. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $7.91 in FY2016 to $29.49 in FY2018.
Based on SEC 10-K filings.
9.54 in FY2025 with a 5-year CAGR of -4.9%. Top quartile in the Health Care sector.
Improved from $8.53 to $9.54 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -20.4%
- 5-Year CAGR
- -4.9%
- 10-Year CAGR
- -
Sector benchmark
+246.2% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 1.5% year-over-year.
- Ranks #4 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2018.
- Lowest capital returned to shareholders per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.54 | +1.5% |
| FY2024 | $9.40 | +10.2% |
| FY2023 | $8.53 | -54.9% |
| FY2022 | $18.91 | +21.7% |
| FY2021 | $15.54 | +26.9% |
| FY2020 | $12.24 | -31.2% |
| FY2019 | $17.81 | -39.6% |
| FY2018 | $29.49 | +233.7% |
| FY2017 | $8.84 | +11.8% |
| FY2016 | $7.91 | +41.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026